Birchtri
讚了
已翻譯
3
Birchtri
讚了
CEO of AIM, Thomas K. Equels, highlights their robust cash position enabling strong clinical and operational performance. He also brings attention to the company's ovarian and pancreatic cancer programs, forecasting value-boosting milestones ahead from them.
1
Birchtri
評論了
$Nxu Inc(NXU.US$ buy under $.036 and later to be the king of Institutional 😀😀😀
5
Birchtri
讚了